Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro

A synthetic entry to derivatives of the new classes of 5-phthalimidouracils and 5-phthalimidobarbituric acids is reported. These 5-phthalimidopyrimidines as well as phthalimido-2,4-difluorobenzenes were designed as analogues of thalidomide, a well known inhibitor of TNF-alpha production. A prelimina...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2001-04, Vol.9 (4), p.1059-1065
Hauptverfasser: GÜTSCHOW, Michael, HECKER, Thomas, THIELE, Andrea, HAUSCHILDT, Sunna, EGER, Kurt
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1065
container_issue 4
container_start_page 1059
container_title Bioorganic & medicinal chemistry
container_volume 9
creator GÜTSCHOW, Michael
HECKER, Thomas
THIELE, Andrea
HAUSCHILDT, Sunna
EGER, Kurt
description A synthetic entry to derivatives of the new classes of 5-phthalimidouracils and 5-phthalimidobarbituric acids is reported. These 5-phthalimidopyrimidines as well as phthalimido-2,4-difluorobenzenes were designed as analogues of thalidomide, a well known inhibitor of TNF-alpha production. A preliminary in vitro investigation of the compounds as inhibitors of the TNF-alpha production was performed. Among the compounds of the present series, 5-ethyl-1-phenyl-5-(tetrafluorophthalimido)barbituric acid and 2-(2,4-difluorophenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione were proved to be potent inhibitors. Both compounds showed inhibitory activity in the lower micromolar range on the LPS-induced TNF-alpha production in human monocytes.
doi_str_mv 10.1016/S0968-0896(00)00323-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70859455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70859455</sourcerecordid><originalsourceid>FETCH-LOGICAL-p167t-8a8266e71e4e694b35f85ed3995547127551409405f78ddaf624ffced83abc2a3</originalsourceid><addsrcrecordid>eNo90EtOwzAQBmALgWgpHAFkCQnBImDHj9jsqoqXVIlFYR1NY5saJXGJk0rlVlyEMxFo6WoW8_2jmUHolJJrSqi8mREtVUKUlpeEXBHCUpaQPTSkXPKEMU330XBHBugoxndCSMo1PUQDSpngUqZD1I0_AUMNZXjrbMTB4XYBpTeh8sbiWzxb1-3CRh97ZLBdQdlB60ONIWJfL_zct6HZ5LoqNLi2RRN-uYOi7yTfX3jZBNMVfyFf45Vvm3CMDhyU0Z5s6wi93t-9TB6T6fPD02Q8TZZUZm2iQKVS2oxabqXmcyacEtYwrYXgGU0zISgnmhPhMmUMOJly5wprFIN5kQIboYvN3H6Hj_6-Nq98LGxZQm1DF_OMKKG5ED0828JuXlmTLxtfQbPO_x_Vg_MtgFhA6RqoCx93TmeEMcV-AEAHehw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70859455</pqid></control><display><type>article</type><title>Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>GÜTSCHOW, Michael ; HECKER, Thomas ; THIELE, Andrea ; HAUSCHILDT, Sunna ; EGER, Kurt</creator><creatorcontrib>GÜTSCHOW, Michael ; HECKER, Thomas ; THIELE, Andrea ; HAUSCHILDT, Sunna ; EGER, Kurt</creatorcontrib><description>A synthetic entry to derivatives of the new classes of 5-phthalimidouracils and 5-phthalimidobarbituric acids is reported. These 5-phthalimidopyrimidines as well as phthalimido-2,4-difluorobenzenes were designed as analogues of thalidomide, a well known inhibitor of TNF-alpha production. A preliminary in vitro investigation of the compounds as inhibitors of the TNF-alpha production was performed. Among the compounds of the present series, 5-ethyl-1-phenyl-5-(tetrafluorophthalimido)barbituric acid and 2-(2,4-difluorophenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione were proved to be potent inhibitors. Both compounds showed inhibitory activity in the lower micromolar range on the LPS-induced TNF-alpha production in human monocytes.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/S0968-0896(00)00323-0</identifier><identifier>PMID: 11354662</identifier><language>eng</language><publisher>Oxford: Elsevier Science</publisher><subject>Aza Compounds - chemical synthesis ; Aza Compounds - pharmacology ; Biological and medical sciences ; Humans ; Immunomodulators ; In Vitro Techniques ; Lipopolysaccharides - pharmacology ; Medical sciences ; Monocytes - drug effects ; Monocytes - metabolism ; Pharmacology. Drug treatments ; Thalidomide - analogs &amp; derivatives ; Thalidomide - chemical synthesis ; Thalidomide - pharmacology ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; Tumor Necrosis Factor-alpha - biosynthesis</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2001-04, Vol.9 (4), p.1059-1065</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=970338$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11354662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GÜTSCHOW, Michael</creatorcontrib><creatorcontrib>HECKER, Thomas</creatorcontrib><creatorcontrib>THIELE, Andrea</creatorcontrib><creatorcontrib>HAUSCHILDT, Sunna</creatorcontrib><creatorcontrib>EGER, Kurt</creatorcontrib><title>Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>A synthetic entry to derivatives of the new classes of 5-phthalimidouracils and 5-phthalimidobarbituric acids is reported. These 5-phthalimidopyrimidines as well as phthalimido-2,4-difluorobenzenes were designed as analogues of thalidomide, a well known inhibitor of TNF-alpha production. A preliminary in vitro investigation of the compounds as inhibitors of the TNF-alpha production was performed. Among the compounds of the present series, 5-ethyl-1-phenyl-5-(tetrafluorophthalimido)barbituric acid and 2-(2,4-difluorophenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione were proved to be potent inhibitors. Both compounds showed inhibitory activity in the lower micromolar range on the LPS-induced TNF-alpha production in human monocytes.</description><subject>Aza Compounds - chemical synthesis</subject><subject>Aza Compounds - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>In Vitro Techniques</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical sciences</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Thalidomide - analogs &amp; derivatives</subject><subject>Thalidomide - chemical synthesis</subject><subject>Thalidomide - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90EtOwzAQBmALgWgpHAFkCQnBImDHj9jsqoqXVIlFYR1NY5saJXGJk0rlVlyEMxFo6WoW8_2jmUHolJJrSqi8mREtVUKUlpeEXBHCUpaQPTSkXPKEMU330XBHBugoxndCSMo1PUQDSpngUqZD1I0_AUMNZXjrbMTB4XYBpTeh8sbiWzxb1-3CRh97ZLBdQdlB60ONIWJfL_zct6HZ5LoqNLi2RRN-uYOi7yTfX3jZBNMVfyFf45Vvm3CMDhyU0Z5s6wi93t-9TB6T6fPD02Q8TZZUZm2iQKVS2oxabqXmcyacEtYwrYXgGU0zISgnmhPhMmUMOJly5wprFIN5kQIboYvN3H6Hj_6-Nq98LGxZQm1DF_OMKKG5ED0828JuXlmTLxtfQbPO_x_Vg_MtgFhA6RqoCx93TmeEMcV-AEAHehw</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>GÜTSCHOW, Michael</creator><creator>HECKER, Thomas</creator><creator>THIELE, Andrea</creator><creator>HAUSCHILDT, Sunna</creator><creator>EGER, Kurt</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro</title><author>GÜTSCHOW, Michael ; HECKER, Thomas ; THIELE, Andrea ; HAUSCHILDT, Sunna ; EGER, Kurt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p167t-8a8266e71e4e694b35f85ed3995547127551409405f78ddaf624ffced83abc2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aza Compounds - chemical synthesis</topic><topic>Aza Compounds - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>In Vitro Techniques</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical sciences</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Thalidomide - analogs &amp; derivatives</topic><topic>Thalidomide - chemical synthesis</topic><topic>Thalidomide - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GÜTSCHOW, Michael</creatorcontrib><creatorcontrib>HECKER, Thomas</creatorcontrib><creatorcontrib>THIELE, Andrea</creatorcontrib><creatorcontrib>HAUSCHILDT, Sunna</creatorcontrib><creatorcontrib>EGER, Kurt</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GÜTSCHOW, Michael</au><au>HECKER, Thomas</au><au>THIELE, Andrea</au><au>HAUSCHILDT, Sunna</au><au>EGER, Kurt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>9</volume><issue>4</issue><spage>1059</spage><epage>1065</epage><pages>1059-1065</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>A synthetic entry to derivatives of the new classes of 5-phthalimidouracils and 5-phthalimidobarbituric acids is reported. These 5-phthalimidopyrimidines as well as phthalimido-2,4-difluorobenzenes were designed as analogues of thalidomide, a well known inhibitor of TNF-alpha production. A preliminary in vitro investigation of the compounds as inhibitors of the TNF-alpha production was performed. Among the compounds of the present series, 5-ethyl-1-phenyl-5-(tetrafluorophthalimido)barbituric acid and 2-(2,4-difluorophenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione were proved to be potent inhibitors. Both compounds showed inhibitory activity in the lower micromolar range on the LPS-induced TNF-alpha production in human monocytes.</abstract><cop>Oxford</cop><pub>Elsevier Science</pub><pmid>11354662</pmid><doi>10.1016/S0968-0896(00)00323-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2001-04, Vol.9 (4), p.1059-1065
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_70859455
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aza Compounds - chemical synthesis
Aza Compounds - pharmacology
Biological and medical sciences
Humans
Immunomodulators
In Vitro Techniques
Lipopolysaccharides - pharmacology
Medical sciences
Monocytes - drug effects
Monocytes - metabolism
Pharmacology. Drug treatments
Thalidomide - analogs & derivatives
Thalidomide - chemical synthesis
Thalidomide - pharmacology
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor Necrosis Factor-alpha - biosynthesis
title Aza analogues of thalidomide : Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A56%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aza%20analogues%20of%20thalidomide%20:%20Synthesis%20and%20evaluation%20as%20inhibitors%20of%20tumor%20necrosis%20factor-%CE%B1%20production%20in%20vitro&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=G%C3%9CTSCHOW,%20Michael&rft.date=2001-04-01&rft.volume=9&rft.issue=4&rft.spage=1059&rft.epage=1065&rft.pages=1059-1065&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/S0968-0896(00)00323-0&rft_dat=%3Cproquest_pubme%3E70859455%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70859455&rft_id=info:pmid/11354662&rfr_iscdi=true